Industry Reports
Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical
Aurobindo Pharma Limited is pleased to announce the acquisition of four cell culture derived biosimilar products from TL Biopharmaceutical AG. As part of this...
Press Releases
Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify Biomarkers for Angelman Syndrome
Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a...
Press Releases
Capsugel Announces Broad Commercial Availability of MAST™ System
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions announced the broad commercial availability of its Modular Automated Sampling Technology™ (MAST)...
Industry Reports
QPSI Announces Acquisition Of Pharmaceutical Packaging Company, International Labs
Quality Packaging Specialists International, LLC (QPSI) has acquired 100% ownership of International Labs, LLC (INL) in an equity exchange transaction. Terms...
News
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma
GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. ...
News
Intarcia Announces FDA Filing Acceptance of NDA for ITCA 650 for the Treatment of Type 2 Diabetes
Intarcia Therapeutics, Inc. announced that the U.S. FDA has accepted for active review its NDA for ITCA 650, an investigational therapy for the treatment...
Clinical Trials
Envisia therapeutics releases interim Env515 phase 2 data results
Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology released an interim analysis of the second cohort...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read